Tumor cells chronically treated with a trastuzumab-maytansinoid antibody-drug conjugate develop varied resistance mechanisms but respond to alternate treatments (Q38913644)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tumor cells chronically treated with a trastuzumab-maytansinoid antibody-drug conjugate develop varied resistance mechanisms but respond to alternate treatments |
scientific article |
Statements
1 reference
Tumor cells chronically treated with a trastuzumab-maytansinoid antibody-drug conjugate develop varied resistance mechanisms but respond to alternate treatments (English)
1 reference
Christopher J O'Donnell
1 reference
Frank Loganzo
1 reference
Xingzhi Tan
1 reference
Matthew Sung
1 reference
Guixian Jin
1 reference
Jeremy S Myers
1 reference
Eugene Melamud
1 reference
Fang Wang
1 reference
Veronica Diesl
1 reference
Maximillian T Follettie
1 reference
Sylvia Musto
1 reference
My-Hanh Lam
1 reference
William Hu
1 reference
Manoj B Charati
1 reference
Kiran Khandke
1 reference
Kenny Sung Kyoo Kim
1 reference
Mike Cinque
1 reference
Judy Lucas
1 reference
Edmund Graziani
1 reference
Andreas Maderna
1 reference
Kim T Arndt
1 reference
Hans-Peter Gerber
1 reference
2 February 2015
1 reference
1 reference
14
1 reference
4
1 reference
952-963
1 reference
Identifiers
1 reference
1 reference